These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 38512652
1. Neuroprotective effects of rutin against cuprizone-induced multiple sclerosis in mice. Nicola MA, Attaai AH, Abdel-Raheem MH, Mohammed AF, Abu-Elhassan YF. Inflammopharmacology; 2024 Apr; 32(2):1295-1315. PubMed ID: 38512652 [Abstract] [Full Text] [Related]
2. Neuroprotective Effects of Telmisartan and Nifedipine Against Cuprizone-Induced Demyelination and Behavioral Dysfunction in Mice: Roles of NF-κB and Nrf2. Abd El Aziz AE, Sayed RH, Sallam NA, El Sayed NS. Inflammation; 2021 Aug; 44(4):1629-1642. PubMed ID: 33709265 [Abstract] [Full Text] [Related]
4. Remyelinating activities of Carvedilol or alpha lipoic acid in the Cuprizone-Induced rat model of demyelination. Ibrahim Fouad G, Ahmed KA. Int Immunopharmacol; 2023 May; 118():110125. PubMed ID: 37028277 [Abstract] [Full Text] [Related]
5. Coenzyme Q10 enhances remyelination and regulate inflammation effects of cuprizone in corpus callosum of chronic model of multiple sclerosis. Khalilian B, Madadi S, Fattahi N, Abouhamzeh B. J Mol Histol; 2021 Feb; 52(1):125-134. PubMed ID: 33245472 [Abstract] [Full Text] [Related]
10. Phosphodiesterase-5 inhibition promotes remyelination by MCP-1/CCR-2 and MMP-9 regulation in a cuprizone-induced demyelination model. Nunes AK, Rapôso C, de Oliveira WH, Thomé R, Verinaud L, Tovar-Moll F, Peixoto CA. Exp Neurol; 2016 Jan; 275 Pt 1():143-53. PubMed ID: 26515692 [Abstract] [Full Text] [Related]
11. The neuroprotective effects of Chalcones from Ashitaba on cuprizone-induced demyelination via modulation of brain-derived neurotrophic factor and tumor necrosis factor α. Rowhanirad S, Taherianfard M. Brain Behav; 2023 Sep; 13(9):e3144. PubMed ID: 37403256 [Abstract] [Full Text] [Related]
12. Combination Therapy of Mesenchymal Stem Cell Transplantation and Astrocyte Ablation Improve Remyelination in a Cuprizone-Induced Demyelination Mouse Model. Madadi S, Shiri E, Pasbakhsh P, Tahmasebi F, Kazemzadeh S, Zibara K, Kashani IR. Mol Neurobiol; 2022 Dec; 59(12):7278-7292. PubMed ID: 36175823 [Abstract] [Full Text] [Related]
13. Repurposing of Secukinumab as Neuroprotective in Cuprizone-Induced Multiple Sclerosis Experimental Model via Inhibition of Oxidative, Inflammatory, and Neurodegenerative Signaling. Abdel-Maged AE, Gad AM, Rashed LA, Azab SS, Mohamed EA, Awad AS. Mol Neurobiol; 2020 Aug; 57(8):3291-3306. PubMed ID: 32514862 [Abstract] [Full Text] [Related]
15. Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study. Ghaiad HR, Nooh MM, El-Sawalhi MM, Shaheen AA. Mol Neurobiol; 2017 Jul; 54(5):3219-3229. PubMed ID: 27067589 [Abstract] [Full Text] [Related]
16. Trifluoperazine reduces cuprizone-induced demyelination via targeting Nrf2 and IKB in mice. Khaledi E, Noori T, Mohammadi-Farani A, Sureda A, Dehpour AR, Yousefi-Manesh H, Sobarzo-Sanchez E, Shirooie S. Eur J Pharmacol; 2021 Oct 15; 909():174432. PubMed ID: 34416238 [Abstract] [Full Text] [Related]
17. Multiple functional therapeutic effects of DL-3-n-butylphthalide in the cuprizone model of demyelination. Wu Y, Dong L, Huang Q, Sun L, Liao Y, Tang Y, Wu Y. Life Sci; 2019 Sep 01; 232():116501. PubMed ID: 31163175 [Abstract] [Full Text] [Related]
18. Ameliorative effects of acetyl-L-carnitine on corpus callosum and functional recovery in demyelinated mouse model. Gharighnia S, Omidi A, Ragerdi Kashani I, Sepand MR, Pour Beiranvand S. Int J Neurosci; 2024 Apr 01; 134(4):409-419. PubMed ID: 35912879 [Abstract] [Full Text] [Related]
19. Effects of Bone Marrow Mesenchymal Stem Cells on Myelin Repair and Emotional Changes of a Cuprizone-Induced Demyelination Model. Lei C, Chen H, Chen K. J Integr Neurosci; 2023 Feb 16; 22(2):40. PubMed ID: 36992584 [Abstract] [Full Text] [Related]
20. The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives. Gharagozloo M, Galleguillos D, Jank L, Sotirchos ES, Smith MD, Garton T, Kumar S, Hussein O, Potluri S, Taylor M, Siu C, Mace JW, Dawson T, Dawson VL, Lee S, Calabresi PA. Neurotherapeutics; 2023 Jul 16; 20(4):1229-1240. PubMed ID: 37296356 [Abstract] [Full Text] [Related] Page: [Next] [New Search]